Global Radiopharmaceutical Market Predicted to Grow at a Moderate Pace Through 2023

Worldwide Market Reports added Latest Research Report titled "Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Radiopharmaceutical Market 2017 Forecast to 2022" to its Large Report database.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The scope of the Report:
This report focuses on the Radiopharmaceutical in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

There are 15 Chapters to deeply display the global Radiopharmaceutical market.
Chapter 1, to describe Radiopharmaceutical Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Radiopharmaceutical, with sales, revenue, and price of Radiopharmaceutical, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Radiopharmaceutical, for each region, from 2012 to 2017;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;
Chapter 12, Radiopharmaceutical market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;
Chapter 13, 14 and 15, to describe Radiopharmaceutical sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Request for Sample Copy of Research Report: https://www.worldwidemarketreports.com/sample/7610

Market Segment by Manufacturers, this report covers Bayer, Triad Isotopes, Lantheus, GE Healthcare, Mallinckrodt, Eli Lilly, Bracco Imaging, SIEMENS, Navidea, Nordion, IBA Group, Jubilant Pharma,
Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Columbia etc.), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers SPECT Radioisotopes, PET Radioisotopes, Other Diagnostic Radioisotopes, Therapeutic Radioisotopes,
Market Segment by Applications can be divided into Oncology, Cardiology, Other

Get Best Discount On This Report: https://www.worldwidemarketreports.com/discount/7610

Table of Contents
1 Market Overview
2 Manufacturers Profiles
3 Global Radiopharmaceutical Market Competition, by Manufacturer
4 Global Radiopharmaceutical Market Analysis by Regions
5 North America Radiopharmaceutical by Countries, Type, Application and Manufacturers
6 Europe Radiopharmaceutical by Countries, Type, Application and Manufacturers
7 Asia-Pacific Radiopharmaceutical by Countries, Type, Application and Manufacturers
8 South America Radiopharmaceutical by Countries, Type, Application and Manufacturers
9 The Middle East and Africa Radiopharmaceutical by Countries, Type, Application and Manufacturers
10 Global Radiopharmaceutical Market Segment by Type
11 Global Radiopharmaceutical Market Segment by Application
12 Radiopharmaceutical Market Forecast (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix

List of Tables and Figures
.
.
Continue

** If you have any special requirements, please let us know and we will offer you the report as you want.

** The Values marked with XX is confidential data. To know more about CAGR figures fill in your information so that our business development executive can get in touch with you.

About WMR

Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703
Email: sales@worldwidemarketreports.com

This release was published on openPR.